Recent Evidence on the Inclusion of Hospice and Palliative Care Physicians in Medicare Shared Savings Program Accountable Care Organization Networks

2018 ◽  
Vol 21 (3) ◽  
pp. 373-375 ◽  
Author(s):  
Julia Driessen ◽  
Turner West
Keyword(s):  
Palliative Care ◽  
Accountable Care Organization ◽  
Care Organization ◽  
Accountable Care ◽  
Organization Networks ◽  
Shared Savings ◽  
Hospice And Palliative Care ◽  
Medicare Shared Savings Program

scholarly journals Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care

Cancer ◽  
2017 ◽  
Vol 124 (3) ◽  
pp. 563-570 ◽  
Author(s):  
Tudor Borza ◽  
Samuel R. Kaufman ◽  
Phyllis Yan ◽  
Lindsey A. Herrel ◽  
Amy N. Luckenbaugh ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Care ◽  
Accountable Care Organization ◽  
Care Organization ◽  
Accountable Care ◽  
Early Effect ◽  
Shared Savings ◽  
Medicare Shared Savings Program

scholarly journals Overlap between Medicare’s Voluntary Bundled Payment and Accountable Care Organization Programs

2019 ◽  
Vol 15 (6) ◽  
pp. 356-358 ◽  
Author(s):  
Amol S Navathe ◽  
Claire Dinh ◽  
Sarah E Dykstra ◽  
Rachel M Werner ◽  
Joshua M Liao
Keyword(s):  
Policy Implications ◽  
Care Organization ◽  
Accountable Care ◽  
Bundled Payment ◽  
Bundled Payments ◽  
Medicare Data ◽  
Shared Savings ◽  
Care Improvement ◽  
Medicare Shared Savings Program ◽  
A Share

Accountable care organizations (ACOs) and bundled payments represent prominent value-based payment models, but the magnitude of overlap between the two models has not yet been described. Using Medicare data, we defined overlap based on attribution to Medicare Shared Savings Program (MSSP) ACOs and hospitalization for Bundled Payments for Care Improvement (BPCI) episodes at BPCI participant hospitals. Between 2013 and 2016, overlap as a share of ACO patients increased from 2.7% to 10% across BPCI episodes, while overlap as a share of all bundled payment patients increased from 19% to 27%. Overlap from the perspectives of both ACO and bundled payments varied by specific episode. In the first description of overlap between ACOs and bundled payments, one in every ten MSSP patients received care under BPCI by the end of our study period, whereas more than one in every four patients receiving care under BPCI were also attributed to MSSP. Policymakers should consider strategies to address the clinical and policy implications of increasing payment model overlap.

Spending Among Patients With Cancer in the First 2 Years of Accountable Care Organization Participation

2018 ◽  
Vol 36 (29) ◽  
pp. 2955-2960 ◽  
Author(s):  
Miranda B. Lam ◽  
Jose F. Figueroa ◽  
Jie Zheng ◽  
E. John Orav ◽  
Ashish K. Jha
Keyword(s):  
Cancer Diagnosis ◽  
Geographic Region ◽  
Care Utilization ◽  
Care Organization ◽  
Accountable Care ◽  
Patients With Cancer ◽  
Cancer Types ◽  
Shared Savings ◽  
Heath Care ◽  
Medicare Shared Savings Program

Purpose Spending on patients with cancer can be substantial and has continued to increase in recent years. Accountable Care Organizations (ACOs) are arguably the most important national experiment to control health care spending, yet how ACOs are managing patients with cancer diagnoses is largely unknown. We aimed to determine whether practices that became ACOs had changes in overall or cancer-specific spending among patients with cancer. Methods Using 2011 to 2015 national Medicare claims, practices that became part of ACOs were identified and matched to non-ACO practices within the same geographic region. We calculated total and category-specific annual spending per beneficiary as well as spending for and utilization of emergency departments, inpatient admissions, hospice, chemotherapy, and radiation therapy. A difference-in-differences model was used to examine changes in spending and utilization associated with ACO contracts in the Medicare Shared Savings Program for beneficiaries with cancer. Results We found that the introduction of ACOs had no meaningful impact on overall spending in patients with cancer (−$308 per beneficiary in ACOs v −$319 in non-ACOs; difference, $11; 95% CI, −$275 to $297; P = .94). We found no changes in total spending in patients within any of the 11 different cancer types examined. Finally, changes in spending and utilization did not meaningfully differ between ACO and non-ACO patients within various categories, including cancer-specific categories. Conclusion Compared with patients with cancer treated at non-ACO practices, being a patient with a cancer diagnosis in a Medicare ACO is not associated with significantly reduced spending or heath care utilization. The introduction of ACOs does not seem to have had any meaningful effect on spending or utilization for patients with a cancer diagnosis.

scholarly journals The Impact of a Home-Based Palliative Care Program in an Accountable Care Organization

2017 ◽  
Vol 20 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Dana Lustbader ◽  
Mitchell Mudra ◽  
Carole Romano ◽  
Ed Lukoski ◽  
Andy Chang ◽  
...  
Keyword(s):  
Palliative Care ◽  
Care Program ◽  
Accountable Care Organization ◽  
Care Organization ◽  
Accountable Care ◽  
Palliative Care Program ◽  
Home Based ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document